ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Arthritis

Arthritis

Nearly half of rheumatoid arthritis patients were able to retain remission for 3 months on a 25 mg weekly dose plus methotrexate. Returning to full dose quickly resolved disease for those who flared.

An Italian study detects a high prevalence of inflammatory abnormalities in the knee joints of older adults, usually absent clinical signs of osteoarthritis.

More good news for Actemra: rheumatoid arthritis patients can safely transition from the intravenous form of the IL-16 blocker to the injectable version.

Prompt action by Alabama rheumatologists has caused Blue Cross Blue Shield to rethink a policy denying all claims for injections into knees with osteoarthritis. But a similar "ban" on hyaluronic acid in neighboring Florida takes effect today.

A major disconnect in psoriatic arthritis treatment: Assessment tools and guidelines largely ignore flares. But over half of patients in two new surveys report severe flares or completely unremitting disease. Both are linked to poor outcomes.

A second biomarker panel shows promise in distinguishing osteoarthritis from rheumatoid arthritis early enough to prevent joint damage. This one relies partly on lack of antibody response to citrullinated proteins in early osteoarthritis.

Pages

Subscribe to Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.